Funding · Company
RECODE THERAPEUTICS, INC.
Menlo Park, CABiotech & Pharma
RECODE THERAPEUTICS, INC. of Menlo Park, CA has disclosed $289M across 2 Form D offerings filed with the SEC between Sep 28, 2023 and Oct 23, 2025.
$289M
Total disclosed
2
Form D offerings
1
Open roles today
Hiring — 1 open role as of Aug 8, 2026
Based in Menlo Park, California, United States. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$260M
Form D · Sep 28, 2023 ↗
Q3 2023
· 3 amendments, first filed Oct 25, 2021
· target $290M
Filing details
HeadquartersMenlo Park, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0001693764Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →